+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Uveitis treatment Market 2020-2026

  • PDF Icon

    Report

  • September 2020
  • Region: Global
  • Orion Market Research Private Limited
  • ID: 5145107
Global Uveitis treatment Market Size, Share & Trends Analysis Report by Disease Type (Anterior Uveitis, Posterior Uveitis, Intermediate Uveitis, and Pan Uveitis) and Treatment Type (Corticosteroids, Immunosuppressant, Monoclonal Antibodies, Cycloplegics, and Others) and Forecast 2020-2026.

The global uveitis treatment market is projected to witness considerable growth during the forecast period. The major factors contributing to the growth of the market include the increasing prevalence of uveitis and rise in autoimmune disorder. In addition, the introduction of novel delivery system and range of products under clinical trial are further expected to propel the market growth during the forecast period. The uveitis treatment market is classified on the basis of diseases type and treatment type. Based on disease type, the market is segmented into anterior uveitis, posterior uveitis, intermediate uveitis, and pan uveitis. Based on treatment type, the market is segmented into corticosteroids immunosuppressant, monoclonal antibodies, cycloplegics, and others. Among these range of treatments, the corticosteroid is estimated to project a considerable CAGR during the forecast period. Corticosteroids are the prime treatment prescribed by the physician for the treatment of the most common type of uveitis, the acute anterior uveitis.

Geographically, the global uveitis treatment market is segmented into North America, Europe, Asia-Pacific, and Rest of the World. North America is expected to contribute a significant share in the global market. The US contributes the major share in the North American uveitis treatment market due to the presence of well-developed healthcare infrastructure and presence of some of the key market players, such as Alimera Sciences, Inc., Santen Pharmaceutical Co., Ltd. In addition, Asia-Pacific is expected to project a considerable growth during the forecast period. This growth is backed by the rising government initiatives towards the establishment of improved healthcare infrastructure and increasing medical tourism, especially in India, China, Malaysia, and Singapore.

The global uveitis treatment market is influenced by product development and advancements conducted by the market players. The key players of the uveitis treatment market include AbbVie Inc., Alimera Sciences, Inc., Santen Pharmaceutical Co., Ltd., Allergan PLC, Cadila Pharmaceuticals Ltd., and EyePoint Pharmaceuticals, Inc. These players are playing a significant role in the growth of the uveitis treatment market by providing various products and adopting several strategies such as merger and acquisition, partnerships and collaboration, technological development, and others.

Research Methodology

The market study of the global uveitis treatment market is incorporated by extensive primary and secondary research conducted by the research team. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. The team collects facts and data related to the market from different geography to provide a better regional outlook.

In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables the analyst to derive the closest possible figures without any major deviations in the actual number. The analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings the authenticity of the reports.

Secondary Sources Include
  • Financial reports of companies involved in the market
  • Whitepapers, research-papers, and news blogs
  • Company websites and their product catalog

The report provides an in-depth analysis of the market size and growth opportunities. The report will serve as a source for 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions.

Market Segmentation

1. Global Uveitis treatment Market Research and Analysis by Diseases Type
2. Global Uveitis treatment Market Research and Analysis by Treatment Type

The Report Covers
  • Comprehensive research methodology of the global uveitis treatment market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global uveitis treatment market.
  • Insights about market determinants which are stimulating the global market.
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Rules & Regulations
3. Competitive Landscape
3.1. Company Share Analysis
3.2. Key Strategy Analysis
3.3. Key Company Analysis
3.3.1. Overview
3.3.2. Financial Analysis
3.3.3. SWOT Analysis
3.3.4. Recent Developments
4. Market Determinants
4.1. Motivators
4.2. Restraints
4.3. Opportunities
5. Market Segmentation
5.1. Global Uveitis Treatment Market by Disease Type
5.1.1. Anterior Uveitis
5.1.2. Posterior Uveitis
5.1.3. Intermediate Uveitis
5.1.4. Pan Uveitis
5.2. Global Uveitis Treatment Market by Treatment Type
5.2.1. Corticosteroids
5.2.2. Immunosuppressant
5.2.3. Monoclonal Antibodies
5.2.4. Cycloplegic Agents
5.2.5. Others (Antiviral and Antibiotics)
6. Regional Analysis
6.1. North America
6.1.1. United States
6.1.2. Canada
6.2. Europe
6.2.1. UK
6.2.2. Germany
6.2.3. Italy
6.2.4. Spain
6.2.5. France
6.2.6. Rest of Europe
6.3. Asia-Pacific
6.3.1. China
6.3.2. India
6.3.3. Japan
6.3.4. Rest of Asia-Pacific
6.4. Rest of the World
7. Company Profiles
7.1. AbbVie Inc.
7.2. Aldeyra Therapeutics, Inc.
7.3. Alimera Sciences, Inc.
7.4. Allergan PLC
7.5. Bausch Health Companies Inc.
7.6. Cadila Pharmaceuticals Ltd.
7.7. Clearside Biomedical, Inc.
7.8. EyePoint Pharmaceuticals, Inc.
7.9. Mylan NV
7.10. Novartis AG
7.11. Pfizer Inc.
7.12. Prometheus Laboratories Inc.
7.13. Santen Pharmaceutical Co., Ltd.
LIST OF TABLES
1. GLOBAL UVEITIS TREATMENT MARKET RESEARCH AND ANALYSIS BY DISEASE TYPE, 2019-2026 ($ MILLION)
2. GLOBAL ANTERIOR UVEITIS TREATMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
3. GLOBAL POSTERIOR UVEITIS TREATMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
4. GLOBAL INTERMEDIATE UVEITIS TREATMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
5. GLOBAL PAN UVEITIS TREATMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
6. GLOBAL UVEITIS TREATMENT MARKET RESEARCH AND ANALYSIS BY TREATMENT TYPE, 2019-2026 ($ MILLION)
7. GLOBAL CORTICOSTEROIDS FOR UVEITIS TREATMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
8. GLOBAL IMMUNOSUPPRESSANTS FOR UVEITIS TREATMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
9. GLOBAL CYCLOPLEGICS FOR UVEITIS TREATMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
10. GLOBAL MONOCLONAL ANTIBODIES FOR UVEITIS TREATMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
11. GLOBAL OTHER TREATMENTS MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
12. GLOBAL UVEITIS TREATMENT MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2019-2026 ($ MILLION)
13. NORTH AMERICAN UVEITIS TREATMENT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2019-2026 ($ MILLION)
14. NORTH AMERICAN UVEITIS TREATMENT MARKET RESEARCH AND ANALYSIS BY DISEASE TYPE, 2019-2026 ($ MILLION)
15. NORTH AMERICAN UVEITIS TREATMENT MARKET RESEARCH AND ANALYSIS BY TREATMENT TYPE, 2019-2026 ($ MILLION)
16. EUROPEAN UVEITIS TREATMENT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2019-2026 ($ MILLION)
17. EUROPEAN UVEITIS TREATMENT MARKET RESEARCH AND ANALYSIS BY DISEASE TYPE, 2019-2026 ($ MILLION)
18. EUROPEAN UVEITIS TREATMENT MARKET RESEARCH AND ANALYSIS BY TREATMENT TYPE, 2019-2026 ($ MILLION)
19. ASIA-PACIFIC UVEITIS TREATMENT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2019-2026 ($ MILLION)
20. ASIA-PACIFIC UVEITIS TREATMENT MARKET RESEARCH AND ANALYSIS BY DISEASE TYPE, 2019-2026 ($ MILLION)
21. REST OF THE WORLD UVEITIS TREATMENT MARKET RESEARCH AND ANALYSIS BY DISEASE TYPE, 2019-2026 ($ MILLION)
22. REST OF THE WORLD UVEITIS TREATMENT MARKET RESEARCH AND ANALYSIS BY TREATMENT TYPE, 2019-2026 ($ MILLION)
LIST OF FIGURES
1. GLOBAL UVEITIS TREATMENT MARKET SHARE BY DISEASE TYPE, 2019 VS 2026 (%)
2. GLOBAL UVEITIS TREATMENT MARKET SHARE BY TREATMENT TYPE, 2019 VS 2026 (%)
3. GLOBAL UVEITIS TREATMENT MARKET SHARE BY GEOGRAPHY, 2019 VS 2026 (%)
4. US UVEITIS TREATMENT MARKET SIZE, 2019-2026 ($ MILLION)
5. CANADA UVEITIS TREATMENT MARKET SIZE, 2019-2026 ($ MILLION)
6. UK UVEITIS TREATMENT MARKET SIZE, 2019-2026 ($ MILLION)
7. FRANCE UVEITIS TREATMENT MARKET SIZE, 2019-2026 ($ MILLION)
8. GERMANY UVEITIS TREATMENT MARKET SIZE, 2019-2026 ($ MILLION)
9. ITALY UVEITIS TREATMENT MARKET SIZE, 2019-2026 ($ MILLION)
10. SPAIN UVEITIS TREATMENT MARKET SIZE, 2019-2026 ($ MILLION)
11. ROE UVEITIS TREATMENT MARKET SIZE, 2019-2026 ($ MILLION)
12. INDIA UVEITIS TREATMENT MARKET SIZE, 2019-2026 ($ MILLION)
13. CHINA UVEITIS TREATMENT MARKET SIZE, 2019-2026 ($ MILLION)
14. JAPAN UVEITIS TREATMENT MARKET SIZE, 2019-2026 ($ MILLION)
15. REST OF ASIA-PACIFIC UVEITIS TREATMENT MARKET SIZE, 2019-2026 ($ MILLION)
16. REST OF THE WORLD UVEITIS TREATMENT MARKET SIZE, 2019-2026 ($ MILLION)

Companies Mentioned

A selection of companies mentioned in this report includes:

  • AbbVie Inc.
  • Aldeyra Therapeutics, Inc.
  • Alimera Sciences, Inc.
  • Allergan PLC
  • Bausch Health Companies Inc.
  • Cadila Pharmaceuticals Ltd.
  • Clearside Biomedical, Inc.
  • EyePoint Pharmaceuticals, Inc.
  • Mylan NV
  • Novartis AG
  • Pfizer Inc.
  • Prometheus Laboratories Inc.
  • Santen Pharmaceutical Co., Ltd.